GENEVA, July 6 -- JETEMA CO., LTD. filed a patent application (KR2024/021145) for “USE OF BOTULINUM TOXIN TYPE E FOR PREVENTING OR TREATING NEUROPATHIC PAIN”. With publication no. WO/2026/141732, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/48
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....